Linking Proteomic and Transcriptional Data through the Interactome and Epigenome Reveals a Map of Oncogene-induced Signaling
Name
Huang-2013-Linking Proteomic an.pdf
Size
1.76 MB
Format
Adobe PDF
Checksum (MD5)
22dbb1b4c5b432b84553c40ccd06e531
Author(s) • • • • • • •
Huang, Shao-shan Carol
Clarke, David C.
Gosline, Sara Jane Calafell
Labadorf, Adam
Chouinard, Candace R.
Gordon, William
Lauffenburger, Douglas A.
Fraenkel, Ernest
Date Issued
February 2013
Journal
PLoS Computational Biology
Publisher
Public Library of Science
Citation
Huang, Shao-shan Carol et al. “Linking Proteomic and Transcriptional Data Through the Interactome and Epigenome Reveals a Map of Oncogene-induced Signaling.” Ed. William Stafford Noble. PLoS Computational Biology 9.2 (2013): e1002887.
Version
Final published version
Abstract
Cellular signal transduction generally involves cascades of post-translational protein modifications that rapidly catalyze changes in protein-DNA interactions and gene expression. High-throughput measurements are improving our ability to study each of these stages individually, but do not capture the connections between them. Here we present an approach for building a network of physical links among these data that can be used to prioritize targets for pharmacological intervention. Our method recovers the critical missing links between proteomic and transcriptional data by relating changes in chromatin accessibility to changes in expression and then uses these links to connect proteomic and transcriptome data. We applied our approach to integrate epigenomic, phosphoproteomic and transcriptome changes induced by the variant III mutation of the epidermal growth factor receptor (EGFRvIII) in a cell line model of glioblastoma multiforme (GBM). To test the relevance of the network, we used small molecules to target highly connected nodes implicated by the network model that were not detected by the experimental data in isolation and we found that a large fraction of these agents alter cell viability. Among these are two compounds, ICG-001, targeting CREB binding protein (CREBBP), and PKF118–310, targeting β-catenin (CTNNB1), which have not been tested previously for effectiveness against GBM. At the level of transcriptional regulation, we used chromatin immunoprecipitation sequencing (ChIP-Seq) to experimentally determine the genome-wide binding locations of p300, a transcriptional co-regulator highly connected in the network. Analysis of p300 target genes suggested its role in tumorigenesis. We propose that this general method, in which experimental measurements are used as constraints for building regulatory networks from the interactome while taking into account noise and missing data, should be applicable to a wide range of high-throughput datasets.
MIT Department
Massachusetts Institute of Technology. Cell Decision Process Center
Massachusetts Institute of Technology. Computational and Systems Biology Program
Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Massachusetts Institute of Technology. Department of Biological Engineering
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1371/journal.pcbi.1002887